240 related articles for article (PubMed ID: 29200404)
1. STAT5BN642H is a driver mutation for T cell neoplasia.
Pham HTT; Maurer B; Prchal-Murphy M; Grausenburger R; Grundschober E; Javaheri T; Nivarthi H; Boersma A; Kolbe T; Elabd M; Halbritter F; Pencik J; Kazemi Z; Grebien F; Hengstschläger M; Kenner L; Kubicek S; Farlik M; Bock C; Valent P; Müller M; Rülicke T; Sexl V; Moriggl R
J Clin Invest; 2018 Jan; 128(1):387-401. PubMed ID: 29200404
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional consequences of the STAT5B
de Araujo ED; Erdogan F; Neubauer HA; Meneksedag-Erol D; Manaswiyoungkul P; Eram MS; Seo HS; Qadree AK; Israelian J; Orlova A; Suske T; Pham HTT; Boersma A; Tangermann S; Kenner L; Rülicke T; Dong A; Ravichandran M; Brown PJ; Audette GF; Rauscher S; Dhe-Paganon S; Moriggl R; Gunning PT
Nat Commun; 2019 Jun; 10(1):2517. PubMed ID: 31175292
[TBL] [Abstract][Full Text] [Related]
3. Enhanced T cell lymphoma in NOD.Stat5b transgenic mice is caused by hyperactivation of Stat5b in CD8+ thymocytes.
Chen B; Yi B; Mao R; Liu H; Wang J; Sharma A; Peiper S; Leonard WJ; She JX
PLoS One; 2013; 8(2):e56600. PubMed ID: 23457589
[TBL] [Abstract][Full Text] [Related]
4. A haunted beast: Targeting STAT5B
Pham HTT; Hengstschläger M; Moriggl R
Mol Cell Oncol; 2018; 5(3):e1435181. PubMed ID: 29876519
[TBL] [Abstract][Full Text] [Related]
5. High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.
Maurer B; Nivarthi H; Wingelhofer B; Pham HTT; Schlederer M; Suske T; Grausenburger R; Schiefer AI; Prchal-Murphy M; Chen D; Winkler S; Merkel O; Kornauth C; Hofbauer M; Hochgatterer B; Hoermann G; Hoelbl-Kovacic A; Prochazkova J; Lobello C; Cumaraswamy AA; Latzka J; Kitzwögerer M; Chott A; Janikova A; Pospíšilova Š; Loizou JI; Kubicek S; Valent P; Kolbe T; Grebien F; Kenner L; Gunning PT; Kralovics R; Herling M; Müller M; Rülicke T; Sexl V; Moriggl R
Haematologica; 2020; 105(2):435-447. PubMed ID: 31123029
[TBL] [Abstract][Full Text] [Related]
6. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Suske T; Sorger H; Manhart G; Ruge F; Prutsch N; Zimmerman MW; Eder T; Abdallah DI; Maurer B; Wagner C; Schönefeldt S; Spirk K; Pichler A; Pemovska T; Schweicker C; Pölöske D; Hubanic E; Jungherz D; Müller TA; Aung MMK; Orlova A; Pham HTT; Zimmel K; Krausgruber T; Bock C; Müller M; Dahlhoff M; Boersma A; Rülicke T; Fleck R; de Araujo ED; Gunning PT; Aittokallio T; Mustjoki S; Sanda T; Hartmann S; Grebien F; Hoermann G; Haferlach T; Staber PB; Neubauer HA; Look AT; Herling M; Moriggl R
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618957
[TBL] [Abstract][Full Text] [Related]
7. A lineage-specific STAT5BN642H mouse model to study NK-cell leukemia.
Klein K; Kollmann S; Hiesinger A; List J; Kendler J; Klampfl T; Randhawa M; Trifinopoulos J; Maurer B; Grausenburger R; Bertram CA; Moriggl RH; Rülicke T; Mullighan CG; Witalisz-Siepracka A; Walter W; Hoermann G; Sexl V; Gotthardt D
Blood; 2024 Mar; ():. PubMed ID: 38498036
[TBL] [Abstract][Full Text] [Related]
8. Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models.
Rivera-Munoz P; Laurent AP; Siret A; Lopez CK; Ignacimouttou C; Cornejo MG; Bawa O; Rameau P; Bernard OA; Dessen P; Gilliland GD; Mercher T; Malinge S
Blood Adv; 2018 Jul; 2(13):1616-1627. PubMed ID: 29986854
[TBL] [Abstract][Full Text] [Related]
9. A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.
Bessette K; Lang ML; Fava RA; Grundy M; Heinen J; Horne L; Spolski R; Al-Shami A; Morse HC; Leonard WJ; Kelly JA
Blood; 2008 Jan; 111(1):344-50. PubMed ID: 17890450
[TBL] [Abstract][Full Text] [Related]
10. STAT5B
Klein K; Witalisz-Siepracka A; Maurer B; Prinz D; Heller G; Leidenfrost N; Prchal-Murphy M; Suske T; Moriggl R; Sexl V
Leukemia; 2019 Sep; 33(9):2336-2340. PubMed ID: 30967617
[No Abstract] [Full Text] [Related]
11. JAK/STAT signaling in hematological malignancies.
Vainchenker W; Constantinescu SN
Oncogene; 2013 May; 32(21):2601-13. PubMed ID: 22869151
[TBL] [Abstract][Full Text] [Related]
12. BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.
MacLeod RA; Nagel S; Drexler HG
Cancer Genet Cytogenet; 2004 Aug; 153(1):88-9. PubMed ID: 15325104
[No Abstract] [Full Text] [Related]
13. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697
[TBL] [Abstract][Full Text] [Related]
14. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
Küçük C; Jiang B; Hu X; Zhang W; Chan JK; Xiao W; Lack N; Alkan C; Williams JC; Avery KN; Kavak P; Scuto A; Sen E; Gaulard P; Staudt L; Iqbal J; Zhang W; Cornish A; Gong Q; Yang Q; Sun H; d'Amore F; Leppä S; Liu W; Fu K; de Leval L; McKeithan T; Chan WC
Nat Commun; 2015 Jan; 6():6025. PubMed ID: 25586472
[TBL] [Abstract][Full Text] [Related]
15. Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases.
Shi M; Shahsafaei A; Liu C; Yu H; Dorfman DM
Leuk Lymphoma; 2015 Jul; 56(7):2087-91. PubMed ID: 25263318
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the MLH1 gene in hematological malignancies.
Matsushita M; Takeuchi S; Yang Y; Yoshino N; Tsukasaki K; Taguchi H; Koeffler HP; Seo H
Oncol Rep; 2005 Jul; 14(1):191-4. PubMed ID: 15944788
[TBL] [Abstract][Full Text] [Related]
17. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in T-cell lymphoid neoplasms.
Bigas A; Rodriguez-Sevilla JJ; Espinosa L; Gallardo F
Exp Hematol; 2022 Feb; 106():3-18. PubMed ID: 34879258
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
20. High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.
Andersson EI; Tanahashi T; Sekiguchi N; Gasparini VR; Bortoluzzi S; Kawakami T; Matsuda K; Mitsui T; Eldfors S; Bortoluzzi S; Coppe A; Binatti A; Lagström S; Ellonen P; Fukushima N; Nishina S; Senoo N; Sakai H; Nakazawa H; Kwong YL; Loughran TP; Maciejewski JP; Mustjoki S; Ishida F
Blood; 2016 Nov; 128(20):2465-2468. PubMed ID: 27697773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
